Aethlon Medical, Inc. (AEMD)

Aethlon Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	6	4	9	22	25	14
Market Cap Growth	-49.89%	-49.89%	-60.95%	-8.59%	74.92%	-21.89%
Enterprise Value	1	-1	-5	6	15	4
PE Ratio	-	-0.36	-0.73	-2.16	-3.12	-2.21
PS Ratio	-	-	15.30	76.47	37.34	21.64
PB Ratio	1.01	0.76	0.58	1.31	2.61	1.50
P/FCF Ratio	-0.42	-0.42	-0.77	-2.22	-3.61	-2.63
P/OCF Ratio	-0.43	-0.43	-0.84	-2.30	-3.64	-2.71
EV/Sales Ratio	-	-	-8.58	20.07	22.29	6.91
EV/EBITDA Ratio	0.04	0.04	0.42	-0.58	-1.87	-0.71
EV/EBIT Ratio	0.04	0.04	0.41	-0.57	-1.86	-0.71
EV/FCF Ratio	0.05	0.05	0.43	-0.58	-2.15	-0.84
Debt / Equity Ratio	0.11	0.11	0.06	0.04	-	0.00
Debt / EBITDA Ratio	-0.05	-0.05	-0.08	-0.06	-	-0.01
Debt / FCF Ratio	-0.06	-0.06	-0.08	-0.06	-	-0.01
Quick Ratio	3.04	3.04	9.74	9.50	7.32	9.20
Current Ratio	3.40	3.40	10.03	9.95	7.53	9.40
Asset Turnover	0	0	0.03	0.01	0.05	0.14
Interest Coverage	-	-	-	-	-	-116.53
Return on Equity (ROE)	-132.70%	-132.70%	-71.50%	-48.60%	-63.10%	-174.20%
Return on Assets (ROA)	-103.20%	-103.20%	-61.40%	-45.70%	-57.50%	-132.20%
Return on Capital (ROIC)	-196.95%	-196.95%	-74.35%	-58.76%	-83.68%	-62.74%
Earnings Yield	-210.17%	-277.32%	-136.92%	-46.30%	-32.05%	-45.30%
FCF Yield	-178.71%	-235.80%	-130.30%	-44.97%	-27.73%	-38.02%
Buyback Yield / Dilution	-22.35%	-22.35%	-39.17%	-22.05%	-254.07%	-182.61%
Total Shareholder Return	-22.35%	-22.35%	-39.17%	-22.05%	-254.07%	-182.61%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).